drugset / Trial / NCT00447876

Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis

NCT00447876

Phase 2/3 Completed 40 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will investigate the hypothesis that the analgesic effect of a single injection of Dysport (200 MU) induces a significant reduction of symptoms in chronic cases of plantar fasciitis.

Timeline

Start
2005-07
Primary completion
2009-01
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 200 iu Other

Indications